LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • CDMO Service
      • Core Value
      • Manufacturing
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
    • LUCATREE Advanced Regenerative Medicine
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

STEM CELL THERAPEUTIC

gmp img5

Successful administration of stem cell dementia treatment drug ‘NEUROSTEM’

gmp img6

Japan patent for dementia treatment technology using stem cell

gmp img3

Stem cell treatment ‘CARTISTEM’ patient cutting the 10 million line

gmp img1

Stem cell cartilage differentiation technology Singapore patent

gmp img5

Clinical thesis for lung treatment ‘PNEUMOSTEM’ published in international academic journal

new 130829

Football Manager Guus Hiddink, receives arthritis surgery with MEDIPOST’s stem cell technology

news 131220

Designated ‘Stem Cell Hair Growth Solution’ research institution by Ministry Commerce, Industry and Energy

gmp img1

Signed license for ‘CARTISTEM’ in India

news 1312091

Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas academic conferences

news 131205

Lung Treatment Medicine ‘PNEUMOSTEM’ designated Orphan Drug by US FDA

gmp img4

Core technology of the Alzheimer’s dementia treatment patented in US

gmp img5

Stem cell dementia treatment 2a clinically approved

Previous 1 … 6 7 8 9 10 Next

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Inc. Treats First U.S. Particip…2026.07.07
MEDIPOST Secures FDA Agreement on Single…2026.06.04
MEDIPOST’s CARTISTEM® Meets All Pr…2026.05.13
MEDIPOST, INC. ANNOUNCES $140 MILLION IN…2026.01.09
MEDIPOST Announces the Exclusive Commerc…2025.12.19

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST